Search Mark
Home / Current Affairs

Doo Prime Vanuatu Limited Has Secured The Professional Indemnity Insurance From Howden


Doo Prime Vanuatu Limited Has Secured

The Professional Indemnity Insurance From Howden

Hong Kong: 20 May 2020

Doo Prime is pleased to announce that we have successfully secured the professional indemnity (PI) insurance provided by Howdena trading name of RKH Specialty Limited, United Kingdom. Doo Prime prides itself as the global leading online broker and we strongly adhere to our values in ensuring utmost security, safety and impartiality for the benefit of the company and our customers.

Through the professional indemnity insurance undertaken by Doo Prime, we have demonstrated our dedication in complying with the higher standards of practice in the online trading industry.

The professional indemnity insurance, often referred to as professional liability insurance or PI insurance, will cover any legal costs and expenses incurred by Doo Prime and any loss or damages incurred as a result of Doo Prime’s liability towards our customers.

The professional indemnity insurance granted meant acknowledgement in Doo Prime as a licenced professional who has demonstrated experience, capability and expertise in the online trading market. The framework of the professional indemnity insurance originates from internationally applicable standards of practice, knowledge, and ethics. It sought to differentiate licenced professionals from the other unregulated entities.

The professional indemnity insurance shall be governed by and construed in all respects in accordance with the laws of Vanuatu, and the parties agree to submit to the non-exclusive jurisdiction of the courts of Vanuatu.

Through our vigilance against complacency, we at Doo Prime remain committed to our corporate vision to offer the highest quality services to retail forex traders and partners.

 

—END—

 

For further information, you may contact Doo Prime via:

 

Phone Number: +44 20 8123 9088 (UK) or +852 5576 9874 (Hong Kong)

 

E-Mail: [email protected]

 

Website: www.dooprime.com

Share to

Current Affairs

China Approves Eli Lilly’s Alzheimer’s Drug Kisunla 

China's medical regulator has approved Eli Lilly's Alzheimer’s treatment, Kisunla, offering patients a new option for early-stage treatment. The approval follows similar endorsements in the United States, Japan, and the U.K., making China the fourth major market to authorize the drug, according to a statement from the company on Tuesday.

2024-12-18 | Current Affairs

Oil Prices Range-Bound Ahead of Fed Rate Decision 

Oil prices remained range-bound in early Asian trading on Tuesday as investors awaited direction from the U.S. Federal Reserve's upcoming interest rate decision and expressed concerns about demand from China. 

2024-12-17 | Current Affairs

China Home Prices See Slowest Drop in 17 Months

China's new home prices fell at their slowest pace in 17 months in November, as government stimulus measures aimed at stabilizing the crisis-hit property sector began to take effect. 

2024-12-16 | Current Affairs